BUSINESS DEVELOPMENT DIRECTOR, CUMMING GLOBAL CENTRE FOR PANDEMIC THERAPEUTICS

• Build world-class research and industry partnerships

• Senior commercialisation role with global impact

• Support groundbreaking innovation and discovery

About the organisation
Established in 1853, the University of Melbourne is a leading international university with a tradition of excellence in teaching and research. With outstanding performance in international rankings, the University is at the forefront of higher education in the Asia-Pacific region and the world. Within the University of Melbourne and supported by the Peter Doherty Institute for Infection and Immunity (the Doherty), the Cumming Global Centre for Pandemic Therapeutics (CGCPT) is a newly created mission-driven, global research centre to enable rapid design and development of therapeutics for future pandemics.

About the role
The Business Development Director CGCPT will provide full lifecycle research commercialisation leadership to the CGCPT, identifying and pursuing strategic partnerships and commercialisation avenues for the Centre’s newly developed research and IP assets. This includes working collaboratively to develop and drive business development strategy, identifying opportunities for growth, collaboration, and commercial partnership between researchers and external partners, and negotiating and closing transactions to the mutual benefit of the stakeholders and within the mission of the CGCPT.  As a newly created, senior role within the CGCPT, the Business Development Director will work to set up the CGCPT’s commercialisation function, leveraging the capabilities and resources of the University of Melbourne’s Faculty of Medicine, Dentistry and Health Sciences (MDHS) and the University’s Research, Innovation and Commercialisation (RIC) Group to set the CGCPT up for a bright future as the world’s leading specialist pandemic therapeutics research centre.

About you
You are a highly regarded research commercialisation professional, with deep expertise in leading and negotiating major life science deals, particularly in relation to industry partnerships, contracts, licensing, start-ups and spinouts. You have strong life science industry experience, sector knowledge (including a thorough understanding of drug development pathways) and networks, and you have enjoyed considerable success in securing funding to support research translation and commercialisation, including from relevant grant schemes, and both commercial and venture funding. Highly credible across both industry and academia, you are collegiate and collaborative builder of strategic relationships, and a naturally empathetic and supportive leader of people. With an entrepreneurial mindset and deep, sector-wide knowledge of how industry works, and know the levers and challenges of industry well enough to be able to consistently guide major business into the CGCPT.  For the right individual, this role represents a career-defining opportunity to set up a new commercialisation function within a well-resourced, rapidly growing research institute with the potential to have significant global impact.

For more information, please contact Matthew Belleghem at SHK via email matthew.belleghem@shk.com.au quoting job #9363 or click ‘Apply for this job’.  Please submit your resume in Microsoft Word format.  Direct and third-party applications will be forwarded to SHK.